Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 4/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.50 |
| ▸ | XBP1 | P17861 | 2/20 | 0.50 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ACP1 | P24666 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1102441 | 0.98 | L3MBTL1 (0.58) | L3MBTL1HTTNPC1RAB9AXBP1 | |
| SCHEMBL25883662 | 0.94 | L3MBTL1 (0.54) | L3MBTL1HTTNPC1RAB9AXBP1 | |
| SCHEMBL20152494 | 0.94 | L3MBTL1 (0.54) | L3MBTL1HTTNPC1RAB9AXBP1 | |
| SCHEMBL17563608 | 0.94 | L3MBTL1 (0.54) | L3MBTL1HTTNPC1RAB9AXBP1 | |
| SCHEMBL12455074 | 0.90 | L3MBTL1 (0.67) | L3MBTL1HTTNPC1RAB9AXBP1 | |
| SCHEMBL28693625 | 0.88 | HTT (0.46) | L3MBTL1HTTNPC1RAB9AXBP1 | |
| SCHEMBL17563612 | 0.88 | NOTUM (0.50) | L3MBTL1HTTNPC1RAB9AXBP1 | |
| SCHEMBL24622601 | 0.87 | L3MBTL1 (0.47) | L3MBTL1HTTNPC1RAB9AXBP1 | |
| SCHEMBL20932543 | 0.87 | ADORA2A (0.47) | L3MBTL1HTTNPC1RAB9AXBP1 | |
| SCHEMBL21661896 | 0.87 | L3MBTL1 (0.47) | L3MBTL1HTTNPC1RAB9AXBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115010673-B | Method for synthesizing 1,3, 5-triazine compounds under visible light-induced metal-free catalysis condition | 河南大学 | 2024-01-30 | — | — | CN | disclosed |
| CN-115010673-A | Method for synthesizing 1,3,5-triazine compound under visible light induction and metal-free catalysis condition | 河南大学 | 2022-09-06 | — | — | CN | disclosed |
| US-20210151683-A1 | LIGHT-EMITTING ELEMENT, AND DISPLAY, ILLUMINATOR, AND SENSOR EACH INCLUDING SAME | TORAY INDUSTRIES, INC. (JP) | 2021-05-20 | — | — | US | disclosed |
| US-9711735-B2 | Delayed fluorescence compound, and organic light emitting diode and display device using the same | LG DISPLAY CO., LTD. (KR) | 2017-07-18 | — | — | US | disclosed |
| US-20160111659-A1 | DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2016-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160111659-A1 | DELAYED FLUORESCENCE COMPOUND, AND ORGANIC LIGHT EMITTING DIODE AND DISPLAY DEVICE USING THE SAME | DRD1, CCND1, CCND2 | L3MBTL1 60/4885HTT 2793/4885NPC1 729/4885 |
| US-20210151683-A1 | LIGHT-EMITTING ELEMENT, AND DISPLAY, ILLUMINATOR, AND SENSOR EACH INCLUDING SAME | CBR3, INTS9, CBR1 | L3MBTL1 208/4885HTT 4642/4885NPC1 2770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.